LDL cholesterol study in people 75+ with heart or blood vessel disease
Part of Heart & circulation clinical trials.
This trial studies how to lower “bad” cholesterol (LDL) in people age 75 and older who have already had heart, brain, or leg/blood-vessel problems from blocked arteries. The goal is to see if the approach helps prevent further cardiovascular events (like heart attack or stroke).
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be age 75 or older
- Have already been diagnosed with clogged-artery disease affecting the heart, brain/carotid arteries (neck), or legs (peripheral arteries)
- Have a baseline LDL (“bad cholesterol”) above a required level for your situation (either before starting cholesterol meds, or while on stable cholesterol meds)
- Have stable health to participate (not in shock, not having certain recent heart attacks, and not too unstable)
- Have acceptable kidney, liver, and muscle blood test results, and no history of certain stroke types
- Be able and willing to sign consent and attend required study visits
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether an educational program can help people with high cholesterol and heart disease get their LDL cholesterol levels lower. It involves watching online videos and working with your doctor to adjust treatments.
This study tests whether a clinical pharmacist-led team can help manage LDL cholesterol levels in patients with heart or blood vessel disease. It aims to improve care for people with conditions like coronary artery disease, stroke, or peripheral artery disease.
This trial compares two ways of guiding cholesterol-lowering treatment in people who have had a heart stent placed. It aims to find which method helps lower heart risks more effectively.
This trial compares two very low LDL-cholesterol targets (below 1.0 vs 1.0-1.39 mmol/L) using extra medications (PCSK9 inhibitors) to see which is safer and better for people at extremely high risk of heart attacks or strokes.
This study looks at whether taking a low- to moderate-dose statin can prevent first-time heart and stroke problems in people age 70 and older. It may help you lower “bad cholesterol” (LDL) and see if that leads to fewer heart events over time.
This study tests a team-based approach to help people with artery disease (like heart attacks or leg blockages) get their cholesterol to a healthier level. If your LDL is above 70, you may benefit from extra support to manage your medications.
Hear when a new Atherosclerotic Cardiovascular Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.